0001567619-21-017415.txt : 20210921 0001567619-21-017415.hdr.sgml : 20210921 20210921194740 ACCESSION NUMBER: 0001567619-21-017415 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210917 FILED AS OF DATE: 20210921 DATE AS OF CHANGE: 20210921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wang Xiaolin CENTRAL INDEX KEY: 0001849181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39219 FILM NUMBER: 211267657 MAIL ADDRESS: STREET 1: C/O REVOLUTION MEDICINES, INC. STREET 2: 700 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revolution Medicines, Inc. CENTRAL INDEX KEY: 0001628171 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 472029180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 415-766-3638 MAIL ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc1.xml FORM 4 X0306 4 2021-09-17 0 0001628171 Revolution Medicines, Inc. RVMD 0001849181 Wang Xiaolin C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063 0 1 0 0 See Remarks Common Stock 2021-09-17 4 S 0 250 30.02 D 12195 D Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Includes 9,800 RSUs. EVP, Clinical Development /s/ Jack Anders, as Attorney-in-fact for Xiaolin Wang 2021-09-21